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Abstract 
Treatment of bulky tumors by traditional radiotherapy has certain limitations. Spatially 
fractionated radiation therapy (GRID) and intensity modulated radiotherapy (IMRT) are 
examples of advanced modulated beam therapies that help in significant reductions in normal 
tissue damage.  GRID refers to the delivery of a single high dose of radiation to a large treatment 
area that is divided into several smaller fields, while IMRT allows improved dose conformity to 
the tumor target compared to conventional three-dimensional conformal radiotherapy. In this 
review, we consider spatially fractionated radiotherapy approaches focusing on GRID and 
IMRT, and present complementary evidence from different studies which support the role of 




The success of traditional radiotherapy in the treatment of bulky or deep-seated tumors is limited 
by poor blood flow, hypoxia in the tumor, poor depth dose distribution and toxicity to the skin 
and surrounding normal tissue. Normal tissue cannot tolerate the large radiation doses required to 
treat the increase in tumor volume successfully. Although significant reductions in normal tissue 
complication have been afforded through the implementation of advanced modulated beam 
therapies such as intensity modulated radiotherapy (IMRT) in the clinic, emerging evidence 
suggests additional benefit may be gained by delivering decreased number of higher doses in 
some tumor types [2, 24]. An additional approach which has the potential to offer further 
improvement is spatially fractionated radiation therapy (GRID). GRID describes the delivery of 
a single high dose fraction to a large treatment area which has been divided into several smaller 
fields with steep dose gradients thus reducing the overall toxicity of the treatment [46]. In this 
review, we consider spatially fractionated radiotherapy approaches focusing on GRID and 
IMRT, and present complementary evidence from different studies which support the role of 
radiation induced signaling effects in the overall radiobiological rationale for these treatments. 
 
2. Classification of radiation induced signaling effects 
The efficacy of ionizing radiation in cancer therapy stems from its ability to induce cell death 
as a consequence of DNA damage due to energy deposition in the cellular environment. Cellular 
radiobiological responses are mediated largely through direct energy deposition in cellular DNA 
or indirectly through reactive oxygen species (ROS) and other free radicals formed during the 
radiolysis of water [25]. 
The classical paradigm in radiation biology which focused on nuclear DNA as the sole target 
of radiation induced damage has been challenged over the last 25 years with an increasing 
amount of evidence demonstrating radiobiological effects in cells which are not directly 
traversed by the radiation field. These effects, termed radiation induced bystander effects 
(RIBEs) generally describe a range of radiation induced signaling effects that have been 
observed under different in vitro and in vivo exposure conditions. 
RIBEs were first identified by Nagasawa and Little [44] who observed chromosome damage 
in the form of sister chromatid exchanges in more than 30% of a cell population under conditions 
in which only 1% of cell nuclei had been targeted using α-particles. Since then, RIBEs have been 
demonstrated using a range of experimental systems with multiple biological endpoints. Despite 
increasing evidence in a growing number of model systems, the implications of RIBEs for 
radiotherapy and cancer risk remain to be fully determined. Whilst conventional approaches to 
study RIBEs have used techniques somewhat removed from clinical exposure scenarios 
including media transfer [42] and co-culture models [5, 6], characterization of RIBEs occurring 
in response to advanced clinical exposures such as intensity modulated radiotherapy (IMRT) and 
GRID will provide additional understanding of their importance in overall radiobiological 
response. 
RIBEs are primarily radiation induced signaling effects that  have been shown to be mediated 
through direct physical cell contact via gap junction intercellular communication (GJIC) [5] or 
through the secretion of diffusible signaling molecules into the surrounding medium  [11, 43, 
57]. The underlying mechanisms mediating response have been extensively studied in a number 
of model systems and shown to include reactive oxygen and nitrogen species (ROS/NOS) 
including nitric oxide (NO), cytokines such as transforming growth factor-β (TGF-β) and 
interleukin-8 (IL-8), which initiate multiple downstream signaling pathways including the 
mitogen activated protein kinases (MAPKs) and nuclear factor-κB (NF-κB) [47].  
Classification of RIBEs is often dependent on the experimental model and exposures 
conditions which are being investigated. A recent framework for the classification of more 
general radiation induced signaling effects based on human radiation exposure scenarios was 
proposed by Blythe and Sykes [8] in which effects were classified into three categories; 
bystander, abscopal and cohort effects. Within this framework, bystander effects are defined for 
human exposure scenarios as radiation induced, signal mediated effects in unirradiated cells 
within an irradiated volume, exposed to a sufficiently low dose that a portion of cells within the 
exposed volume, survive [8] . These effects are relevant for whole and partial body exposures to 
very low doses, such as those from background radiation, high altitude flights and ingested 
radioactive potassium.  
The second class of effects are abscopal effects, defined as radiation induced effects in 
unirradiated tissues occurring outside of an irradiated volume.  Abscopal effects have been 
observed for more than 60 years as systemic radiation effects in some patients following 
radiotherapy.  They do not appear to be dose dependent, making them particularly relevant to the 
partial body exposures typically delivered during conformal radiotherapy. Abscopal effects are 
rarely recognized in the clinic and so their importance in radiotherapy response remains 
controversial [28]. 
The final class of effects are defined as cohort effects. These describe the component of 
overall radiobiological response in irradiated cells which is not a consequence of direct energy 
deposition in the target cell but rather due to communication between cells within an irradiated 
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volume. Cohort effects are relevant for any exposures where the majority of a cell population is 
exposed to significant dose and whilst this interpretation is relatively uncommon in the literature, 
there is increasing evidence that intercellular signaling plays a role in overall radiation response.  
Although this framework clearly defines different classes of radiation induced signaling 
effects, which may potentially impact the overall radiobiological responses, it is unlikely that 
they occur independently in the advanced clinical scenario where patients are exposed to 
complex spatially and temporally modulated beam profiles with nearby cells receiving vastly 
different doses. It is consequently difficult to investigate either of these effects in isolation as the 
effects may stem from the same or similar cellular signaling origin and may be interpreted as 
different consequences of the same generalized RIBEs. 
3. Observations of RIBEs under modulated beam conditions 
Spatially fractionated radiotherapy (GRID) 
Spatially fractionated radiotherapy (GRID) refers to the delivery of a single high dose 
fraction of radiation by dividing a large treatment area into several smaller fields, thus reducing 
the overall toxicity of the treatment [46]. GRID has been successfully used in the treatment of 
bulky and deep-seat tumors. GRID may be combined with traditional dose/time fractionated 
radiation therapy or used along with other treatment modalities, including chemotherapy to 
achieve better control of bulky tumors and it extends the treatment course minimally.  
GRID is not a new technique. In the early 1900s, radiation was performed through a 
perforated screen to successfully deliver higher than normal doses of radiation, safely and 
without causing complication due to skin toxicity.  In the 1950s, GRID was routinely used along 
with orthovoltage radiation to treat deep seated tumors with minimal skin and subcutaneous 
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tissue toxicity [36, 40].  However, with the development of megavoltage radiation, better depth 
dose distribution and reduced skin toxicity could be achieved and thus the utility of GRID 
became obsolete, until physicians started facing difficulties in treating bulky and advanced 
tumors. GRID involves delivery of high doses of radiation through a specially made GRID 
collimator or a multileaf collimator, such that the entire target does not receive a uniform 
radiation dose. Instead, only the target directly under the open areas receives irradiation.   
Recently, it has also been demonstrated that GRID could be applied to deep seated and irregular 
geometries using the advanced capabilities of a tomotherapy system as well [58].  
Clinical results of GRID obtained thus far are very encouraging. Mohiuddin et al.  [39, 40] 
constructed a special GRID collimator using 7 centimeters of lead consisting of 250 equidistant 
holes. Seventy one patients with advanced bulky tumors were treated with 15 Gy radiation 
delivered by GRID to various sites including lung, head and neck, gastrointestinal, sarcomas, 
gynecologic, genitourinary and skin. The patients were treated with GRID alone or GRID 
followed by fractionated radiation therapy or GRID followed by fractionated radiation therapy 
and surgery. An overall 75.7% response rate was observed at the end of the study and 78% 
response rate was observed for palliative treatment and 72.5% for mass effect. A complete 
response of 16% was observed for all treatments. In another study, 27 patients with advanced 
head and neck cancer were treated with GRID along with radiation therapy (Group 1) or GRID 
followed by radiation therapy and planned neck dissection (Group 2) [26]. The overall neck 
control rate was 93% for Group 1 with a disease specific survival of 50% and morbidity was 
limited to mild soft tissue damage. In Group 2, an 85% pathologic complete response rate was 
observed, as well as, 92% neck control rate, 85% disease specific survival and surgical morbidity 
was limited to wound healing complications. Penagaricano et al. [46] used a multileaf collimator 
based GRID design in a cerrobend alloy 7 centimeters in thickness. Fourteen patients with 
advanced head and neck cancers were evaluated. These patients received GRID followed by 
chemo-radiotherapy. The overall control rate of the GRID treated tumor volume was 93%, 
overall neck and primary tumor control rate was 86%. The overall survival was 64% and disease 
specific survival was found to be 79% and 57% patients exhibited disease free survival.  
Although the GRID dose distribution is non-uniform, the regression of the tumor mass receiving 
GRID has exhibited uniform regression clinically [26, 46]. One plausible explanation might be 
the enhanced reoxygenation of the tumor following GRID, since the tumor was treated with 
standard chemoradiation following the GRID dose.  A recent study using spatially fractionated 
microbeam therapy indeed observed marked improvements in tumor oxygenation over the first 2 
weeks following exposure [22].  
Induction of tumor necrosis factor α and ceramide, as well as down regulation of 
transforming growth factor β1 have been observed following GRID [50, 51]. In addition, GRID 
therapy leads to increased cytokine production, resulting in broad systemic effects [46]. It is also 
possible that bystander effects might play a role in killing adjacent non-irradiated or partially 
irradiated cells. Studies focusing on the type of inter-cellular communication that might exist 
between the adjacent cells in the open and closed areas of GRID, might provide valuable 
information on the mechanisms involved in the promising clinical results observed. 
GRID-induced bystander effects: 
We recently evaluated the ability of spatially fractionated radiation (GRID) in murine 
carcinoma cells following exposure to a single dose of 10 Gy, analogous to the high single doses 
used in spatial fractionation [3]. The GRID experiments were performed in a Small Animal 
Conformal Radiation Research System (SACRRS). A programmable robotic arm is used to 
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obtain precise positioning of the target/beam, for both therapy and imaging. During the GRID 
irradiation, the cells are placed on the “palm” of the robot and aligned with the X-ray beam. The 
GRID pattern of irradiation is then created by programming the robot platform to move 
perpendicular normal to the X-ray beam direction (Figure 1). The cells were then irradiated at 10 
Gy using GRID, to create a pattern of nearly 50:50 direct and bystander exposure pattern of 9 
circular fields, 12 mm in diameter with a center-to-center distance of 18 mm. Confluent murine 
mammary carcinoma (SCK) and head and neck sarcoma (SCCVII) cells were irradiated using 
GRID. The regions that were exposed to 10 Gy irradiation were considered as “directly 
irradiated” and the adjacent cells which did not receive direct irradiation, but were exposed to 
indirect radiation (i.e., scattering) which amounted to a valley dose of approximately 1 Gy, were 
considered as “bystander cells”. The cells were harvested at various time points and re-plated to 
determine clonogenic survival. A significant bystander killing in cells adjacent to irradiated 
regions was observed compared to the sham treated controls. The decrease in survival of cells in 
the adjacent regions was found to be more than that expected from exposure to only background 
‘valley’ or scatter doses, suggesting the existence of true cytotoxic bystander effects following 
GRID irradiation (Figure 2).  
Experiments using real-time PCR arrays specific for mouse DNA damage and cellular stress 
response pathways were used to determine GRID-induced bystander gene expression changes in 
mouse head and neck carcinoma (SCCVII) cells [3]. The bystander (GRID adjacent) cells 
exhibited increased expression of genes involved in DNA repair, cell cycle arrest and apoptosis 
immediately following exposure or 4 h after exposure. In some instances the increase persisted 
up to 24 h post GRID irradiation. Increased expression of antioxidant, heat shock and chaperone 
genes immediately following irradiation or 4 h post GRID exposure in the bystander cells. A 
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significant increase in expression of these genes in the GRID irradiated cells was not observed. 
In contrast, it has been reported that p53 related genes exhibited minimal activation in bystander 
cells, while the genes involved in NFκB were activated to equal degrees in direct and bystander 
cells [20, 21] following alpha particle irradiation of fibroblasts. In these studies, a significantly 
higher level of the genes encoding Glutathione peroxidase, Gpx1 and superoxide dismutase, 
Sod1 was observed in the bystander cells compared to sham treated controls [3]. These 
antioxidant enzymes have been known to be important in the cellular defense to oxidative stress 
[19, 38]. It has been hypothesized that proteins able to withstand freezing and thawing, might be 
responsible for transmitting the bystander signal from irradiated to naïve bystander cells [27, 31, 
43, 45, 52]. Reactive oxygen species [29, 31, 33], growth factors and cytokines [7] have been 
implicated in the maintenance of the bystander signal.  Our results suggest that secreted factors 
that lead to reactive oxygen species are a very likely candidate for the effects observed, since we 
observed the greatest increase in expression of antioxidant genes immediately following GRID 
treatment [3].   
 
Intensity modulated radiotherapy (IMRT) 
RIBEs have been demonstrated using a wide range of experimental approaches at the single, 
multi-cellular and whole organism level. Increasingly sophisticated clinical approaches have 
been driven by technological advancements using radiation microbeams to more accurately 
target the tumor volume. highly focused low energy, micron sized beam to single cells or sub-
cellular targets.  
Whilst early experimental approaches such as media transfer and cell co-culture have 
provided clear evidence of radiation induced bystander effects, they have largely been conducted 
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under conditions which do not accurately represent the multi-cellular environment or replicate 
radiation exposures in vivo. 
A number of novel approaches have been taken to investigate RIBEs in vitro under exposure 
conditions which more accurately replicate those during clinical exposures. These approaches 
have focused on characterizing cellular responses following complex spatial and temporal dose 
distributions which are delivered during typical advanced radiotherapy such as intensity 
modulated radiotherapy (IMRT). IMRT allows improved dose conformity to the tumor target 
compared to conventional three-dimensional conformal radiotherapy (3D-CRT). Clinical 
evidence for IMRT has shown significant improvements in tumor control afforded by dose 
escalation along with reduced acute and late toxicity in certain tumor types [53]. Although IMRT 
improves dose distribution to the tumor target, multiple entry fields results in increased volumes 
of normal tissue exposed to low dose compared to conventional delivery techniques. These dose 
baths may have important implications for secondary cancer risk, however, the clinical 
significance of this remain to be fully determined [23, 48]. 
Since 2005 several groups have attempted to characterize RIBEs under more clinically 
relevant exposure scenarios within respect to beam energy, delivery time and dose distributions 
(Table 1). Using a wedge filter to deliver modulated 6 MV photon beam, Suchowerska et al. [54] 
demonstrated decreased survival in low dose regions with improved survival in high dose 
regions with both responses being dependent on intercellular communication between the high 
and low dose regions . This work was complemented by the subsequent study of Claridge 
Mackonis et al. [34] who investigated cell survival under 3 different beam configurations using a 
multi-leaf collimator (MLC); a uniform field, a quarter field (25% of cells exposed) and a striped 
configuration (25% of the cells exposed in 3 parallel strips). The authors showed differential cell 




survival responses in different regions of the beam profiles compared to uniform exposures. 
These results showed close agreement with that of Suchowerska et al. [54], demonstrating 
decreased survival in low dose regions and increased survival in high dose regions. 
Several studies have further characterized radiobiological responses to modulated fields 
under different of beam configurations and energies. Butterworth et al., [10] determined cell 
survival responses to modulated and non-modulated field configurations delivered using an MLC 
generated step wedge. This study showed no difference in cell survival response to uniform dose 
distributions delivered using a uniform field or parallel opposed step wedges and no difference in 
response to modulated exposures using shallow dose gradients. A further study by Butterworth et 
al. [11] determined cell survival responses occurring in- and out-of-field following modulated 
beam exposures in which 50 % of the cells were shielded using a multi-leaf collimator (MLC) as 
shown in Figure 3. In agreement with data from other authors, significantly reduced survival was 
observed outside of the radiation field compared to the level of response predicted on the basis of 
scattered dose alone, along with indications of enhanced survival in-field when the cell 
populations were free to communicate. Additionally, out-of-field responses were shown to be 
dependent, at least in part on nitric oxide signaling and field size.  
A number of reports are now available that further characterize out-of-field responses in 
different cell lines at different energies, dose rates and using clinically relevant treatment plans 
[9, 37, 55]. In addition, these effects have also been demonstrated for clinical proton beams 
delivered using passive scattering and pencil beam scanning techniques [9].  
Whilst these studies have provided evidence for RIBEs under clinically relevant beam 
profiles, they are limited to two dimensions, lacking cellular architecture and physiological 
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context which may be of significant importance pertaining to the tumor microenvironment. 
RIBEs have been demonstrated at the whole organism level in a number of in vivo model 
systems under different exposure conditions [13]. Historically, the first in vivo evidence of 
RIBEs was provided by the identification of clastogenic factors obtained from the serum of 
irradiated patients which showed cell damaging activity when transferred onto cultures of 
unirradiated lymphocytes [18, 32]. Since then, most experimental models used to investigate 
RIBEs have involved partial body exposures and are therefore classified as abscopal effects, 
which have been observed clinically for many years and were originally defined as systemic 
radiation effects following local radiotherapy [41].  
Experimentally, abscopal effects have been demonstrated in a number of models. 
Camphausen et al. [12], showed significant reduction in the growth of tumors implanted to the 
dorsal midline when the legs of the animals were irradiated in C57BL/6. In the same model, 
Koturbash et al., [30] showed induction of DNA damage in skin tissue up to 7 mm away from 
the irradiated site following partial body exposure. Another important model which has been 
used to demonstrate the dose and spatial dependency of abscopal effects increasing causing 
tumorigenesis is the Patched-1 (Ptch1+/-) mouse [35].  
Although RIBEs have clearly been demonstrated in vivo, the systems in which they have 
been investigated do not accurately replicate typical exposure conditions during radiotherapy, 
presenting an important opportunity. Whilst next generation higher energy microbeams will 
provide improved subcellular targeting accompanied with advanced imaging, presenting there is 
a need to determine RIBEs under conditions analogous to clinical protocols. This may be 
perhapsis potentially possible through the application of tumor bearing animals models in 
combination with advanced small animal radiation research platforms [56] and presents an 
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exciting opportunity to determine the precise implications of RIBEs for radiotherapy and cancer 
risk following clinically relevant exposures. 
RIBEs are not necessarily restricted to exposure to ionizing radiation. Recently, the ability of 
genotoxic stress producing agents, other than ionizing radiation, to induce bystander effects have 
been reported. Chemotherapeutic drugs, such as chloroethylnitrosurea [17] , paclitaxel [1], 
mitomycin C [4, 49] and phleomycin [4] can induce bystander effects through secretion of media 
soluble factors.  In addition, photosensitizers [16], heat [15] and photodynamic stress [14] have 
all been reported to cause some type of bystander effect.   Therefore, the true nature of bystander 
effects appears to be a cells stress related phenomenon and not necessarily a unique by-product 
of radiation damage or a specific type of treatment. 
 
Perspective 
Evidence from a range of studies focusing on understanding the role of RIBEs under 
clinically relevant exposure conditions from both GRID and IMRT have shown remarkable 
similarity in radiobiological response. Steep dose gradients associated with IMRT and GRID 
overall suggest significantly greater than expected decreases in survival out-of-field and 
unexpected increases in survival in-field. These observations may have important implications 
for radiotherapy and a more detailed understanding of the mechanisms mediating response may 
result in improved tumor control whilst reducing normal tissue toxicity. These benefits may be 
realized only by defined RIBEs in the context of the tumor microenvironment where, amongst 
other important factors, oxygen tension is likely to have a significant impact. Understanding the 
contribution of RIBEs following high radiation dose exposure will facilitate the development of 
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Figure 1:   A Small Animal Conformal Radiation Research System (SACCRS) was used in the 
GRID irradiation experiments [3]. 
 
Figure 2: Cells were irradiated using spatially fractionated radiation to evaluate bystander 
effects. The cells were irradiated at a peak dose of 10 Gy using a brass collimator to create a 
GRID pattern of 9 open circular areas, 12 mm in diameter with a center-center distance of 18 
mm. The bystander cells were harvested from the valley dose region along the diagonal lines 
illustrated, which represents about 10% of the total radiation [3]. 
 
Figure 3: Experimental setup (a) and schematic representation of dose profile and culture flask 
configuration (b) for intensity modulated beam experiments. Cells were irradiated in a single T75 
culture flask (Intercellular communication intact) or as two T25 culture flasks (Intercellular 
communication inhbited) using a multileaf collimator (MLC) in which 50% of the cell 
population were placed out-of-field. Penumbra regions for each of the flask configurations were 
excluded from analysis [11] .  
